Evidence map›Paper›PMID 32210554›Full record

ArticleInternational journal of nanomedicine2020

Zirconium Oxide Thin Films Obtained by Atomic Layer Deposition Technology Abolish the Anti-Osteogenic Effect Resulting from miR-21 Inhibition in the Pre-Osteoblastic MC3T3 Cell Line.

Aleksandra Seweryn, Ariadna Pielok, Krystyna Lawniczak-Jablonska, Rafal Pietruszka, Klaudia Marcinkowska, Mateusz Sikora, Bartlomiej S Witkowski, Marek Godlewski, Krzysztof Marycz, Agnieszka Smieszek

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. MicroRNA-loaded biomaterials for osteogenesis.Frontiers in bioengineering and biotechnology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Bone marrow stromal cells (BMSCs CD45Journal of cellular and molecular medicine · 2021
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Aleksandra SewerynInstitute of Physics, Polish Academy of Sciences, Warsaw PL-02668, Poland.ORCID 0000-0001-8590-8250
Ariadna PielokWroclaw University of Environmental and Life Sciences, Department of Experimental Biology, Wroclaw PL-50375, Poland.ORCID 0000-0002-5461-8856
Krystyna Lawniczak-JablonskaInstitute of Physics, Polish Academy of Sciences, Warsaw PL-02668, Poland.ORCID 0000-0003-1042-570X
Rafal PietruszkaInstitute of Physics, Polish Academy of Sciences, Warsaw PL-02668, Poland.ORCID 0000-0001-7834-5680
Klaudia MarcinkowskaWroclaw University of Environmental and Life Sciences, Department of Experimental Biology, Wroclaw PL-50375, Poland.ORCID 0000-0002-0610-0462
Mateusz SikoraWroclaw University of Environmental and Life Sciences, Department of Experimental Biology, Wroclaw PL-50375, Poland.ORCID 0000-0002-9965-587X
Bartlomiej S WitkowskiInstitute of Physics, Polish Academy of Sciences, Warsaw PL-02668, Poland.ORCID 0000-0003-0108-6902
Marek GodlewskiInstitute of Physics, Polish Academy of Sciences, Warsaw PL-02668, Poland.ORCID 0000-0002-1701-5458
Krzysztof MaryczWroclaw University of Environmental and Life Sciences, Department of Experimental Biology, Wroclaw PL-50375, Poland.ORCID 0000-0003-3676-796X
Agnieszka SmieszekWroclaw University of Environmental and Life Sciences, Department of Experimental Biology, Wroclaw PL-50375, Poland.ORCID 0000-0002-7314-9821
Institute of Physics · PLWrocław University of Environmental and Life Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe development of the field of biomaterials engineering is rapid. Various bioactive coatings are created to improve the biocompatibility of substrates used for bone regeneration, which includes formulation of thin zirconia coatings with pro-osteogenic properties. The aim of this study was to assess the biological properties of ZrO METHODOLOGY: The cytocompatibility of the obtained layers was analysed using the mice pre-osteoblastic cell line (MC3T3) characterized by decreased expression of microRNA 21-5p (miR-21-5p) in order to evaluate the potential pro-osteogenic properties of the coatings. The in vitro experiments were designed to determine the effect of ZrO

resultsThe analysis revealed that the obtained coatings are cytocompatible and may increase the metabolism of pre-osteoblast, which was correlated with increased mitochondrial membrane potential and extensive development of the mitochondrial network. The obtained coatings affected the viability and proliferative status of cells, reducing the population of actively dividing cells. However, in cultures propagated on ZrO DISCUSSION: The data obtained indicate that ZrO

Indexed as

AnimalsBiocompatible MaterialsCell LineCell ProliferationCell SurvivalGene Expression RegulationMaterials TestingMiceMicroRNAsNanotechnologyOsteoblastsOsteogenesisUp-RegulationZirconiumBiocompatible MaterialsMicroRNAsMIRN21 microRNA, mouseZirconiumzirconium oxideALDcytocompatibilityosteoblasts precursorspro-osteogenic propertieszirconia-based coatings

Identifiers

PMID32210554
PMCPMC7069564
OpenAlexW3009296554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.